all report title image
  • Published On : Mar 2022
  • Code : CMI1309
  • Industry : Medical Devices
  • Pages : 154
  • Formats :

Breast implants are artificial devices (prostheses), which are surgically inserted into the breast, for the augmentation of the breast, which is called as mammoplasty. Breast implants are made up of silicone shells that are filled with either silicone gel or saline (sterile salt water).

Breast implantation is performed for multiple reasons such as women with mastectomy (breast removal due to cancer), women whose breast size has reduced after pregnancy, weight loss or aging, women with asymmetrical breasts, and women who want to improve their self-esteem and body image.

In the breast implants category, silicone breast implants are highly preferred options among women seeking breast augmentation procedure, as they appear more firm and appealing in comparison to saline breast implants. Breast implants comes in different sizes and shapes ranging from low profile to high profile implants.

The global breast implants market is estimated to be valued at US$ 1,299.9  million in 2021 and is expected to exhibit a CAGR of 4.2% over the forecast period (2021-2028)

Figure 1. Global Breast Implants Market Share (US$ Mn), By Region, 2021

Breast Implants  | Coherent Market Insights

The increasing patients of breast cancer is expected to drive growth of the global breast implants market over the forecast period.

For instance, in 2020, according to the World Health Organisation (WHO) there were 2.3 million women diagnosed with breast cancer and 685, 000 deaths globally.

CMI table icon

Breast Implants Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 1,299.9 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 4.2% 2028 Value Projection: US$ 1,739.0 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Saline Implant, Silicone Implant
  • By Shape: Round, Anatomical
  • By Application: Breast Augmentation, Breast Reconstruction
  • By Texture: Smooth, Textured
  • By End User: Hospitals, Clinics, Others
Companies covered:

Abbvie, Inc, CEREPLAS, Establishment Labs S.A., GC Aesthetics, GROUPE SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co., Ltd., HansBiomed Co., Ltd., Ideal Implant Inc, Laboratoires Anios, Mentor Worldwide LLC, Polytech Health & Aesthetics GmbH, Shanghai Kangning Medical Device Co., Ltd, Sientra, Inc., and Silimed.

Growth Drivers:
  • The increasing patients of breast cancer
  • The increasing research and development activities for the faster recovery and less post-operative pain
  • The increasing product launches and approvals
Restraints & Challenges:
  • The risk associated with breast implants

Figure 2. Global Breast Implants Market Value (%), By Product Type, 2021

Breast Implants  | Coherent Market Insights

The increasing research and development activities for the faster recovery and less post-operative pain is expected to drive the market growth over the forecast period.

For instance, in April 2021, Establishment Labs has completed enrolment of one hundred patient in Motiva MIA IRB study, where the study demonstrates a significant advancement in breast aesthetics, relative to traditional augmentation surgery, MIA offers a shorter procedure time without the need for general anaesthesia, reduced recovery time, and lower post-operative pain.          

The increasing product launches and approvals are expected to drive the market growth over the forecast period.

For instance, in December 2021, GC Aesthetics, Inc (GCA), a privately held medical technology company providing aesthetics solutions for global healthcare market,  launched PERLE, a highly innovative line of smooth breast implant that features a proprietary surface technology.

Global Breast Implants Market – Impact of Coronavirus (Covid-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 281,808,270 cases and 5,411,759 deaths due to coronavirus disease (COVID-19) were reported till December 29, 2021, across the globe.

The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions.

For instance, according to the America Society of Plastic Surgeons, number of breast augmentation procedures performed in 2019 were 287,085 and the number reduced to 193,073 in 2020.

Global Breast Implants Market – Restraint

The risk associated with breast implants such as breast pain, changes in nipple, additional surgeries, breast implants associated anaplastic large cell lymphoma (BIA-ALCL), connective tissue disease, issue in breast feeding, and capsular contracture factors are expected to hinder the growth of global breast implants market over the forecast period. For instance, in 2020, according to American Society of Plastic Surgeons 36,367 breast implants removal (Augmentation patients only) were performed in the U.S.

Key Players

Major players operating in the global breast implant market include Abbvie, Inc, CEREPLAS, Establishment Labs S.A., GC Aesthetics, GROUPE SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co., Ltd., HansBiomed Co., Ltd, Ideal Implant Inc, Laboratoires Anios, Mentor Worldwide LLC, Polytech Health & Aesthetics GmbH, Shanghai Kangning Medical Device Co., Ltd, Sientra, Inc, and Silimed.

Breast implants are medical devices implanted under the breast tissue or chest muscle to increase breast size (augmentation) or to replace breast tissue that has been removed due to cancer or that has failed to develop properly due to severe breast abnormality (reconstruction). They are also used in revision surgeries to correct or improve the result of an original surgery. There are two types of breast implants approved in the U.S., which includes saline filled and silicone gel filled, both the types have a silicone outer shell that vary in size, shell thickness, shell surface texture, and shape.

Increasing awareness of breast reconstruction procedure has led to higher number of women opting for mastectomy procedure. Moreover, raising awareness of women towards breast augmentation procedures for beauty enhancement has resulted in higher breast implant procedures.

According to American Society of Plastic Surgeons, 193,073 breast augmentation surgeries were performed in U.S

Market Dynamics

The increasing prevalence of breast cancer, rising research and development activities for the development of novel breast implants, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global breast implants market over the forecast period.

For instance, according to breast cancer organization, in 2021, an estimated 281,550 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S, along with 49,290 new cases of non-invasive breast cancer.

Key features of the study:

  • This report provides an in-depth analysis of the global breast implants market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global breast implants market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbvie, Inc, CEREPLAS, Establishment Labs S.A., GC Aesthetics, GROUPE SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co., Ltd., HansBiomed Co., Ltd, Ideal Implant Inc, Laboratoires Anios, Mentor Worldwide LLC, Polytech Health & Aesthetics GmbH, Shanghai Kangning Medical Device Co., Ltd, Sientra, Inc, and Silimed
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global breast implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global breast implants market

Detailed Segmentation:

  • Global Breast Implants Market, By Product Type:
    • Saline Implant
    • Silicone Implant
  • Global Breast Implants Market, By Shape:
    • Round
    • Anatomical
  • Global Breast Implants Market, By Application:
    • Breast Augmentation
    • Breast Reconstruction
  • Global Breast Implants Market, By Texture:
    • Smooth
    • Textured
  • Global Breast Implants Market, By End User:
    • Hospitals
    • Clinics
    • Others
  • Global Breast Implants Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbvie, Inc.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • CEREPLAS
    • Establishment Labs S.A
    • GC Aesthetics
    • GROUPE SEBBIN SAS
    • Guangzhou Wanhe Plastic Materials Co., Ltd.
    • HansBiomed Co., Ltd
    • Ideal Implant Inc
    • Laboratoires Anios
    • Mentor Worldwide LLC
    • Polytech Health & Aesthetics GmbH
    • Shanghai Kangning Medical Device Co., Ltd
    • Sientra, Inc
    • Silimed

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global breast implants market size is estimated to be valued at US$ 1,299.9 million in 2021 and is expected to exhibit a CAGR of 4.2% between 2021 and 2028.
The increasing product launches and approvals are expected to drive the market growth over the forecast period.
Silicone implants expected to hold a major market share in the market.
North America is expected to hold the largest market share in the market. 
Major factors hampering growth of the market are the risk associated with breast implants such as breast pain, changes in nipple, additional surgeries, breast implants associated anaplastic large cell lymphoma, connective tissue disease, issue in breast feeding, and capsular contracture.
Major players operating in the market include Abbvie, Inc, CEREPLAS, Establishment Labs S.A., GC Aesthetics, GROUPE SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co., Ltd., HansBiomed Co., Ltd, Ideal Implant Inc, Laboratoires Anios, Mentor Worldwide LLC, Polytech Health & Aesthetics GmbH, Shanghai Kangning Medical Device Co., Ltd, Sientra, Inc., and Silimed

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo